Chris Bibler is currently a Key Account Manager at Precigen, specializing in rare disease and T-cell immune therapy for the treatment of RRP. Prior to this role, Chris served as a Senior Territory Account Specialist at Bristol Myers Squibb from 2024 to 2025, and worked as a Medical Account Specialist II at Regeneron Pharmaceuticals from 2020 to 2024. From 2005 to 2015, Chris held the position of Executive Specialty Representative at Merck, focusing on women's health and vaccines, and also worked as an Oncology Specialty Sales Representative during that time.
This person is not in the org chart
This person is not in any teams
This person is not in any offices